1 hr ago

Singapore Cancer Centre Reports Nearly 20% Rise in Indian Patients

More Indian patients went to a cancer centre in Singapore in 2025.

The centre said their number increased by nearly 20 percent.

Many of these patients had cancer that was already advanced or had not responded to treatment.

This can make curing the disease more difficult.

Doctors said finding the exact type of cancer is very important.

Tests can include scans, biopsies and checks for genetic changes in the cancer.

Some advanced cancers can still be controlled for many years with the right treatment.

The doctor also said preventing tobacco and betel nut use and finding cancer early can improve outcomes.

Key facts

Patient growth: Indian patient numbers at Parkway Cancer Centre rose by nearly 20% year on year in 2025.
Advanced cases: About 60–70% of Indian patients had advanced or treatment-resistant cancers.
Potentially curable cases: About 30% were potentially at a curable stage.
Diagnostic timeline: The centre aims to complete imaging, biopsy, pathology and molecular profiling within 48 hours in most cases.
Treatment costs: Drug costs can range from a few hundred Singapore dollars to SGD 14,000 per cycle.
Treatment duration: Some chemotherapy patients may receive six cycles, typically one every 21 days, while others need longer treatment.
Indian outreach: Parkway Cancer Centre operates a CanHOPE office in Delhi focused on cancer awareness, prevention, detection and care.

theprint.in · 2 hrs ago